Great Speculations

Contributor Group|Markets
Great Speculations' contributor page is devoted to investing ideas that will help make you wiser and richer. Most articles will contain actionable advice.
SOCIAL
article image
54 minutes ago

Up 9% Year To Date, Will Chevron’s Gains Continue Following Q1 Results?

We expect the company’s stock to likely see little to no movement with its revenues and earnings matching expectations in its first quarter results.

ByTrefis TeamContributor
article image
18 hours ago

Outperforming Pharma Stock Ready To Run Higher

Pharmaceutical and healthcare giant McKesson (MCK) suffered several pullbacks on the charts in recent weeks, just after touching a record high of $543 on April 4.

article image
241 views21 hours ago

Is An Earnings Beat In The Cards For Honeywell?

While Honeywell will benefit from increased aftermarket services for commercial aerospace, a tough comparison for warehouse automation may weigh on its sales growth.

ByTrefis TeamContributor
article image
209 views22 hours ago

Will Higher Keytruda Sales Drive Merck's Q1

Merck’s HPV vaccine – Gardasil – is expected to see its sales rise in the mid-teens.

ByTrefis TeamContributor
article image
527 views23 hours ago

Is Procter & Gamble Stock Appropriately Priced At $160?

The company reported revenue of $20.2 billion and adjusted earnings of $1.52 per share, compared to the consensus estimates of $20.4 billion and $1.41, respectively.

ByTrefis TeamContributor